Saturday, April 04, 2026 5:06:28 PM
Very interesting. Thanks Senti!
So just to refresh the timeline for people:
August 28th: Company announced the agreement to acquire Advent.
October 9th: HTA Inspection
October 24th: Advent Deal closed
November 20th: Company PR that the Advent C Suite Construction is underway
November 28th: 2nd CHM Meeting
December 15th: Advent MIA & MIA(IMP) Certificates both updated
February 10th: HTA Final Report Issued (internally only it seems)
February 26/27th: Possible 3rd CHM Meeting date (like mRESVIA). As Senti suggests, maybe the CHM was waiting for this HTA Licence Update to green light.
April 2nd: HTA Licence Issued
-----------------------------------------------------------------------------
April 28th: Significant MHRA Regulatory update. Possible publication of Guidance on use of RWD on ECTs
May 2nd: Theoretical maximum number of allowable clock on + clock off days past CHM Meeting #2. But this lands on a Saturday so:
May 5th: NWBO Takeoff Tuesday! 🤞
So just to refresh the timeline for people:
August 28th: Company announced the agreement to acquire Advent.
October 9th: HTA Inspection
October 24th: Advent Deal closed
November 20th: Company PR that the Advent C Suite Construction is underway
November 28th: 2nd CHM Meeting
December 15th: Advent MIA & MIA(IMP) Certificates both updated
February 10th: HTA Final Report Issued (internally only it seems)
February 26/27th: Possible 3rd CHM Meeting date (like mRESVIA). As Senti suggests, maybe the CHM was waiting for this HTA Licence Update to green light.
April 2nd: HTA Licence Issued
-----------------------------------------------------------------------------
April 28th: Significant MHRA Regulatory update. Possible publication of Guidance on use of RWD on ECTs
May 2nd: Theoretical maximum number of allowable clock on + clock off days past CHM Meeting #2. But this lands on a Saturday so:
May 5th: NWBO Takeoff Tuesday! 🤞
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
